SlimJaro reviews after struggling with weight for years. See how this helped me shed pounds, backed by real results and ...

This trend typically involves putting your placenta into capsules you can take as pills, and there are even companies selling custom-made and do-it-yourself products online. While some mammals may ...

Novo Nordisk, U.S. Biotech Company Team Up to Create Obesity Pills FRIDAY, May 16, 2025 (HealthDay News) — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to ...

FRIDAY, May 16, 2025 (HealthDay News) — Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes and other ...

Baton Rouge-based Judge Jewel Welch denied the Louisiana Attorney General's request to dismiss a lawsuit filed last year by opponents of the law, who argue that the reclassification of the pills is ...

Louisiana, which has one of the strictest abortion bans in the country, became the first state last year to heighten the classification of the two pills. Passage of the measure by the GOP ...

Last month, the government announced that the morning-after pill would be made free from pharmacies later this year. While emergency contraception is already free from most GPs, getting it without ...

U.S. health regulators announced plans Tuesday to phase out fluoride-containing supplements sometimes used to strengthen children’s teeth, opening a new front in Health Secretary Robert F.

But those popular supplements may not be worth the money. With age, our bodies produce less collagen. As collagen levels decline the skin sags and becomes wrinkled. A variety of factors can ...

after the drugmaker reported positive results from a late-stage trial of a GLP-1 treatment for Type 2 diabetes and obesity in pill form. The last time the stock rose as much was June 29 ...

Because it is taken as a simple once-daily pill, it could be easier for patients to stay consistent with their treatment, potentially improving long-term outcomes. The development of Obicetrapib ...